Quick Takeaways
- Atlas Venture Fund XI, L.P. filed SCHEDULE 13G/A for DYNE THERAPEUTICS, INC. COMMON STOCK, $0.0001 PAR VALUE (DYN).
- Disclosed ownership: 4%.
- Date of event: 30 Sep 2025.
Atlas Venture Fund XI, L.P. - 30 Sep 2025 SCHEDULE 13G/A Report for DYNE THERAPEUTICS, INC. COMMON STOCK, $0.0001 PAR VALUE (DYN)
- Filing Manager
- Atlas Venture Fund XI, L.P.
- Reporting Manager
- Atlas Venture Associates XI, L.P.
- Symbol
- DYN
- Shares outstanding
- 142,836,750 shares
- Disclosed Ownership
- 5,713,470 shares
- Ownership
- 4%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Nov 2025, 16:23:17 UTC
- Date of event
- 30 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Atlas Venture Fund XI, L.P. disclosed 4% ownership in DYNE THERAPEUTICS, INC. COMMON STOCK, $0.0001 PAR VALUE (DYN) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Nov 2025, 16:23.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (9)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Atlas Venture Fund XI, L.P. | 4% | 5,697,508 | 0 | 5,697,508 | /s/ Ommer Chohan | By: Atlas Venture Associates XI, L.P., its general partner, By: Atlas Venture Associates XI, LLC, its general partner, By: Ommer Chohan, its CFO | |
| Atlas Venture Associates XI, L.P. | 4% | 5,713,470 | 0 | 5,713,470 | /s/ Ommer Chohan | By: Atlas Venture Associates XI, LLC, its general partner, By: Ommer Chohan, its CFO | |
| Atlas Venture Associates XI, LLC | 4% | 5,713,470 | 0 | 5,713,470 | /s/ Ommer Chohan | Ommer Chohan, its CFO | |
| Atlas Venture Opportunity Fund I, L.P. | 1% | 1,458,568 | 0 | 1,458,568 | /s/ Ommer Chohan | By: Atlas Venture Associates Opportunity I L.P., its GP, By: Atlas Venture Associates Opportunity I LLC, its GP, By: Ommer Chohan, its CFO | |
| Atlas Venture Associates Opportunity I, L.P. | 1% | 1,458,568 | 0 | 1,458,568 | /s/ Ommer Chohan | By: Atlas Venture Associates Opportunity I LLC, its GP, By: Ommer Chohan, its CFO | |
| Atlas Venture Associates Opportunity I, LLC | 1% | 1,458,568 | 0 | 1,458,568 | /s/ Ommer Chohan | Ommer Chohan, its CFO | |
| Atlas Venture Opportunity Fund II, L.P. | 1.4% | 1,958,427 | 0 | 1,958,427 | /s/ Ommer Chohan | By: Atlas Venture Associates Opportunity II L.P., its GP, By: Atlas Venture Associates Opportunity II LLC, its GP, By: Ommer Chohan, its CFO | |
| Atlas Venture Associates Opportunity II, LP | 1.4% | 1,958,427 | 0 | 1,958,427 | /s/ Ommer Chohan | By: Atlas Venture Associates Opportunity II LLC, its GP, By: Ommer Chohan, its CFO | |
| Atlas Venture Associates Opportunity II, LLC | 1.4% | 1,958,427 | 0 | 1,958,427 | /s/ Ommer Chohan | Ommer Chohan, its CFO |